Ads
related to: phases of clinical trials
Search results
Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
Pharmaceutical Technology via Yahoo Finance· 5 hours agoThe involvement of two optimistic agents to tackle symptoms and exacerbations as a fixed-dose...
Zydus Lifesciences concludes subject enrolment in Phase II ALS trial
Clinical Trials Arena via Yahoo Finance· 5 days agoZydus Lifesciences has announced the conclusion of subject enrolment in the Phase II clinical trial ...
...Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating...
WTNH-TV New Haven· 2 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of...
HI-Bio reports findings from Phase II trial in kidney transplant recipients
Clinical Trials Arena via Yahoo Finance· 2 days agoHuman Immunology Biosciences (HI-Bio) has reported positive outcomes from the Phase II clinical ...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 39 minutes agoIt has soared by over 177% this year, outperforming the S&P 500, Nasdaq 100, and the iShars...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 4 hours agoGlobalData is the parent company of Pharmaceutical Technology. AstraZeneca is investigating its...
...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...
Benzinga· 5 days agoSHANGHAI, May 24, 2024 /PRNewswire/ -- Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative ...
NS Pharma reports data from Phase III Duchenne treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoSimilar trends were also observed in the placebo group, resulting in no statistically significant...
NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression...
WTNH-TV New Haven· 1 day ago...demonstrated a similar antidepressant effect (MADRS reduction ~50%) compared to lurasidone, the Standard of Care drugNRX-101 demonstrated a 58% relative reduction in time to sustained remission from suicidality (P=.05) compared to lurasidoneNRX-101 demonstrated a 76% reduction in symptoms of...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 16 minutes agoSalt Lake City, Utah, May 29, 2024 (GLOBE NEWSWIRE) -- Poster presented today at American Society of Clinical Pharmacology (ASCP) Annual Meeting in Miami ...